Mahfuzul Majumdar, MD
Anesthesiology · Los Angeles, CANPI 1295984078
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,012 of the $1,510 with a category attached, or 67.1%. Edwards Lifesciences accounts for 61.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $926 and has fallen 87.0% since, to $121 in 2024. Among anesthesiology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 14 payments — averaging $107.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$926
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$125
- Boehringer Ingelheim$121
- Abbott$121
- AstraZeneca$119
- AbbVie$98
What the payments were for
- Travel & lodging$49733%
- Food & beverage$1,01267%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 8 | $926 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $125 |
| Boehringer Ingelheim | 1 | $121 |
| Abbott | 2 | $121 |
| AstraZeneca | 1 | $119 |
| AbbVie | 1 | $98 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,510 in reported general payments places this provider in the 90th percentile of 5,717 anesthesiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 12 | $86 |
| Ciprofloxacin Hcl | 16 | $79 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $78 |
| Ibuprofen | 19 | $70 |
| Cephalexin | 12 | $64 |
| Ondansetron Hcl | 11 | $56 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Los Angeles
- Maxime CannessonLos Angeles$336K
- Moody MakarLos Angeles$252K
- Jonathan JahrLos Angeles$223K
- Michael BottrosLos Angeles$182K
- David BoldtLos Angeles$153K
- Natale NaimLos Angeles$66K
- Anahat DhillonLos Angeles$63K
- Bita FarrellLos Angeles$58K
- Dane SaksaLos Angeles$52K
- Emily MethangkoolLos Angeles$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.